Australia TGA ARTG record

Injectable Bone Substitute - Bone matrix implant, synthetic

Australia TGA ARTG Registered Device · Life Healthcare Pty Ltd · Biomatlante SA ZA les Quatre Nations · Class III · Started December 01, 2022

Good Name: Life Healthcare Pty Ltd - Injectable Bone Substitute - Bone matrix implant, synthetic

Device classification

Risk Class: Class III
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: December 01, 2022
Effective Date: December 01, 2022

Sponsor

Name: Life Healthcare Pty Ltd

Manufacturer

Name: Biomatlante SA ZA les Quatre Nations
Country: France
Address: 5 Rue Edouard Belin, Vigneux De Bretagne, 44360

Intended purpose

The Injectable Bone Substitute is intended for use to reconstruct bony voids or bone gaps of the skeletal system (e.g. extremities, spine and pelvis).

About this record

Access comprehensive regulatory information for Injectable Bone Substitute - Bone matrix implant, synthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Life Healthcare Pty Ltd, manufactured by Biomatlante SA ZA les Quatre Nations in France. The device registration started on December 01, 2022.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.